People | January 13, 2022
Merck KGaA appoints Global R&D Head & CSO for healthcare business sector
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
It adds Rezurock (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Subscribe To Our Newsletter & Stay Updated
